Table 1 Indications for warfarin use and comorbid conditions (N = 63)
Variable | n (%) |
|---|---|
Indication for warfarin use | |
 DVT | 41 (65.1%) |
 Afib | 14 (22.2%) |
 Cardiac thrombus | 4 (6.5%) |
 PE | 7 (11.1%) |
 Prophylaxis for DVT | 2 (3.2%) |
 Internal jugular vein thrombosis | 1 (1.6%) |
Comorbidities | |
 Cardiovascular related conditions | 33 (52.4%) |
 Infections |  |
  HIV | 8 (12.7%) |
  TB | 5 (7.9%) |
  Other infections | 15 (23.8%) |
 GIT disorders | 10 (15.9%) |
 Neoplasms | 8 (12.7%) |
 Blood disorders | 7 (11.1%) |
 Respiratory related conditions | 6 (9.5%) |
 Endocrine, nutritional and metabolic disorders | 6 (9.5%) |
 Genitourinary tract disorders | 5 (7.9%) |
 Mental and behavioural disorders | 5 (7.9%) |
 Post-pregnancy related conditions | 2 (3.2%) |
 Skin and subcutaneous tissue diseases | 3 (4.8%) |
 Musculoskeletal disorders | 2 (3.2%) |
 Nervous system disorders | 1 (1.6%) |